We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecules Turn on Long-Term Memory in Immune System

By Biotechdaily staff writers
Posted on 28 May 2004
Researchers have identified two molecules (TL and CD8aa) that cooperate to trigger immune cells to develop into long-lived memory cells to fight recurring infections, a finding that may aid the development of longer-lasting, more-potent vaccines for viruses such as HIV and West Nile. More...
The finding was reported in the April 23, 2004, issue of Science.

During an infection immunce cells are activated to fight the infectious assault. These activated immune cells are programmed to undergo death immediately at the end of such a defense response. However, a few survive as memory cells. These cells are important since they can persist for the life of the individual and will act rapidly upon encountering the same infection later in life to provide immediate protection.

"These two molecules are induced during this defensive response and provide survival signals to the responding immune cells, which allow them to develop into long-lived memory cells,” said Hilde Cheroutre, Ph.D., from the La Jolla Institute for Allergy & Immunology (LIAI, La Jolla, CA, USA). "With more of these memory cells, the body can better fight the infection should it arise again. This has major implications for the development of vaccines that will protect people longer and more effectively against disease.”




Related Links:
LIAI

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
LAIR2 Antibody Pair Set
LAIR2 Antibody Pair [Biotin]
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.